Xvivo Perfusion
466.5
SEK
+1.08 %
XVIVO
NASDAQ Stockholm
Medical Equipment & Services
Health Care
5 following
+1.08%
+3.21%
-9.24%
+10.15%
+41.58%
+52.2%
+86.23%
+175.38%
+2,355.26%
Xvivo Perfusion is a medical technology company. The company provides solutions for lung transplantation. Examples of products that the company delivers include needles, organ storage, and cooling solutions. The products are resold to clinics and research institutes around the global market, with the largest business presence in the Nordics and Europe. The company was established via a spin-off from Vitrolife in 2012 and is headquartered in Gothenburg.
Read moreMarket cap
14.69B SEK
Turnover
22.14M SEK
Revenue
597.54M
EBIT %
0.7 %
P/E
151.95
Dividend yield-%
-
Financial calendar
28/1
2025
Annual report '24
24/4
2025
Interim report Q1'25
25/4
2025
General meeting '24
ShowingAll content types
Inklusion av patienter färdigställd fem månader tidigare än planerat i XVIVOs amerikanska kliniska studie för hjärtpreservation
Enrollment completed five months early in the US clinical trial evaluating XVIVO’s heart preservation technology
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools